First Tracks Biotherapeutics

TRAXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.393 B

$38.99 +1.01%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

35,730,843

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#136Avalyn PharmaAVLN$1.40B
#137Latigo BiotherapeuticsLTGO$1.40B
#138First Tracks BiotherapeuticsTRAX$1.39B
#139Lb PharmaceuticalsLBRX$1.39B
#140OmerosOMER$1.34B

What if First Tracks Biotherapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$847,280.71

Per share 21,731× higher

Bitcoin $1.72T

$48,132.19

Per share 1,234× higher

Nvidia $5.48T

$153,364.92

Per share 3,933× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for First Tracks Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.